Iron Status in Women of Reproductive Age Reproductive Age

Status Completed

Clinical Trial Summary

Analyzed iron status, HFE mutations and ethnicity for women in five primary care centers in the United States and Canada using de-identified data from the HEIRS study.

Clinical Trial Description

HEIRS included a cross-sectional screening study of 101,168 patients, 25 years of age or older, in the primary care setting. Participants were recruited from four centers in the U.S .and one in Canada from February 2001 to February 2003. We will evaluate results for women aged 25-44 years of age who are self-reported as Asian, Black, Hispanic or White. The lower detection limit for the serum ferritin (SF) assay in the HEIRS study was 15 μg/L and therefore the definition of iron deficiency will be SF concentration ≤ 15 μg/L. Elevated SF concentrations, possibly indicative of elevated iron stores, will be classified by two definitions: 1) SF concentration > 300 μg/L and 2) SF >200 μg/L in combination with TSAT >45%. Proportions will be compared by Pearson's chi-square. Logistic regression models will be used to identify independent associations with measures of iron deficiency and elevated iron stores. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03276247
Study type	Observational
Source	University of Illinois at Chicago
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2016
Completion date	August 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03990181` - Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement	N/A
Recruiting	`NCT06213402` - RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Withdrawn	`NCT01927913` - Treatment of Iron Overload Requiring Chelation Therapy	Phase 2
Completed	`NCT03317873` - The Effect of Genetic Variation in TMPRSS6 Gene (SNP rs855791) on Oral Iron Absorption: an Iron Stable Isotope Study	N/A
Enrolling by invitation	`NCT03512743` - Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal Women
Recruiting	`NCT06151548` - Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism.	Phase 4
Recruiting	`NCT00687518` - Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers	N/A
Not yet recruiting	`NCT05510440` - Supplementation With Altha-aminoacids and Systemiec Inflammatory Response in Long-distance Runners.	N/A
Recruiting	`NCT04008147` - Hepcidin and Glucose Metabolism	N/A
Recruiting	`NCT06250595` - European Rare Blood Disorders Platform (ENROL)
Completed	`NCT03013439` - Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)	Phase 1
Completed	`NCT01477112` - Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals	N/A
Completed	`NCT04458662` - Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise
Not yet recruiting	`NCT02882477` - Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy	Phase 2/Phase 3
Recruiting	`NCT05586867` - Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients